MARKOLF HANEFELD: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Very Low Density Lipoprotein Overproduction Is Maximally Expressed in Early Insulin Resistant States

JENS PIETZSCH, ULRICH JULIUS, CHRISTIAN KIRCH, SABINE FISCHER, MARKOLF HANEFELD

Journal:

Annals of the New York Academy of Sciences

Year:

1999

Language:

english

File:

PDF, 100 KB

english, 1999

2

Acarbose Treatment and the Risk of Cardiovascular Disease and Hypertension in Patients With Impaired Glucose Tolerance

Chiasson, Jean-Louis, Josse, Robert G., Gomis, Ramon, Hanefeld, Markolf, Karasik, Avraham, Laakso, Markku, for The STOP-NIDDM Trial Research Group,

Journal:

JAMA The Journal of the American Medical Association

Year:

2003

Language:

english

File:

PDF, 141 KB

english, 2003

3

Stable isotope ratio analysis of amino acids: the use of N(O,S)-ethoxycarbonyl trifluoroethyl ester derivatives and gas chromatography/mass spectrometry

Jens Pietzsch, Ulrich Julius, Markolf Hanefeld

Journal:

Rapid Communications in Mass Spectrometry

Year:

1997

Language:

english

File:

PDF, 91 KB

english, 1997

4

Lipidomic strategies to analyze type 2 diabetes from early insulin resistance to the metabolic syndrome

Peter Ugocsai, Gerhard Liebisch, Carsta Köhler, Markolf Hanefeld, Gerd Schmitz

Journal:

Chemistry and Physics of Lipids

Year:

2009

Language:

english

File:

PDF, 54 KB

english, 2009

5

Impact of the individual components of the metabolic syndrome and their different combinations on the prevalence of atherosclerotic vascular disease in type 2 diabetes: the Diabetes in Germany (DIG) study

Markolf Hanefeld, Carsta Koehler, Silvina Gallo, Inge Benke, Petra Ott

Journal:

Cardiovascular Diabetology

Year:

2007

Language:

english

File:

PDF, 571 KB

english, 2007

6

Cardiovascular benefits and safety profile of acarbose therapy in prediabetes and established type 2 diabetes

Markolf Hanefeld

Journal:

Cardiovascular Diabetology

Year:

2007

Language:

english

File:

PDF, 715 KB

english, 2007

7

Effect of the addition of rosiglitazone to metformin or sulfonylureas versus metformin/sulfonylurea combination therapy on ambulatory blood pressure in people with type 2 diabetes: A randomized controlled trial (the RECORD study)

Michel Komajda, Paula Curtis, Markolf Hanefeld, Henning Beck-Nielsen, Stuart J Pocock, Andrew Zambanini, Nigel P Jones, Ramon Gomis, Philip D Home, The RECORD Study Group

Journal:

Cardiovascular Diabetology

Year:

2008

Language:

english

File:

PDF, 634 KB

english, 2008

8

Restoring early-phase insulin secretion – the new goal in type 2 diabetes management

Markolf Hanefeld

Journal:

Practical Diabetes

Year:

2001

Language:

english

File:

PDF, 147 KB

english, 2001

9

Hyperinsulinemia in patients with low fractional catabolic rate of triglycerides

Ulrich Julius, Wolfgang Leonhardt, Jan Schulze, Karl Schollberg, Markolf Hanefeld, Hans Haller

Journal:

Acta Diabetologica

Year:

1981

Language:

english

File:

PDF, 424 KB

english, 1981

10

Hyperlipidämie und Fibrate unter besonderer Berücksichtigung des Diabetes

Elena Henkel, Markolf Hanefeld

Journal:

Year:

2001

File:

PDF, 97 KB

2001

11

Postprandiale Hyperglykämie als Risikofaktor bei Herz-Kreislauf-Erkrankungen

Markolf Hanefeld, Frank Schaper

Journal:

Year:

2004

File:

PDF, 417 KB

2004

12

Das metabolische Syndrom: „common soil“ für Diabetes und Atherosklerose

Markolf Hanefeld, Wolfgang Metzler, Carsta Köhler, Frank Schaper

Journal:

Year:

2006

File:

PDF, 588 KB

2006

13

Effect of Acarbose on Vascular Disease in Patients with Abnormal Glucose Tolerance

Markolf Hanefeld, Frank Schaper, Carsta Koehler

Journal:

Cardiovascular Drugs and Therapy

Year:

2008

Language:

english

File:

PDF, 163 KB

english, 2008

14

Multimodale Therapie von Fettstoffwechselstörungen

Annett Stahn, Markolf Hanefeld

Journal:

Clinical Research in Cardiology Supplements

Year:

2011

Language:

german

File:

PDF, 2.20 MB

german, 2011

15

Prandial hyperglycemia: Is it important to track and treat?

Hanefeld Markolf, Schaper Frank

Journal:

Current Diabetes Reports

Year:

2005

Language:

english

File:

PDF, 683 KB

english, 2005

16

Metabolic Basis of Low High Density Lipoprotein in Subjects with Impaired Glucose Tolerance

JENS PIETZSCH, ULRICH JULIUS, MARKOLF HANEFELD

Journal:

Annals of the New York Academy of Sciences

Year:

1999

Language:

english

File:

PDF, 65 KB

english, 1999

17

The “Glucose Pentagon”: Assessing Glycemic Control of Patients with Diabetes Mellitus by a Model Integrating Different Parameters from Glucose Profiles

Schönauer, Martin, Achermann, Frank, Schnell, Oliver, Thomas, Andreas, Hanefeld, Markolf, Ziegelasch, Hans-Jürgen, Mastrototaro, John, Heinemann, Lutz

Journal:

Diabetes Technology & Therapeutics

Year:

2009

Language:

english

File:

PDF, 485 KB

english, 2009

18

Prandial insulin substitution with insulin lispro or insulin lispro mid mixture vs. basal therapy with insulin glargine: A randomized controlled trial in patients with type 2 diabetes beginning insulin therapy

Christof Kazda, Hiltrud Hülstrunk, Karin Helsberg, Frank Langer, Thomas Forst, Markolf Hanefeld

Journal:

Journal of Diabetes and its Complications

Year:

2006

Language:

english

File:

PDF, 249 KB

english, 2006

19

Clinical efficacy and safety of cerivastatin: summary of pivotal Phase IIb/III studies

Jean Davignon, Markolf Hanefeld, Noriaki Nakaya, Donald B Hunninghake, William Insull Jr, Leiv Ose

Journal:

The American Journal of Cardiology

Year:

1998

Language:

english

File:

PDF, 590 KB

english, 1998

20

The Role of Acarbose in the Treatment of Non–Insulin-Dependent Diabetes Mellitus

Markolf Hanefeld

Journal:

Journal of Diabetes and its Complications

Year:

1998

Language:

english

File:

PDF, 265 KB

english, 1998

21

Very fast ultracentrifugation of serum lipoproteins: influence on lipoprotein separation and composition

Jens Pietzsch, Sabine Subat, Sigrid Nitzsche, Wolfgang Leonhardt, Klaus-Ulrich Schentke, Markolf Hanefeld

Journal:

Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism

Year:

1995

Language:

english

File:

PDF, 914 KB

english, 1995

22

Impact of concentrations of glycated hemoglobin, α-tocopherol, copper, and manganese on oxidation of low-density lipoproteins in patients with type I diabetes, type II diabetes and control subjects

Wolfgang Leonhardt, Markolf Hanefeld, Grit Müller, Cornelia Hora, Dieter Meissner, Peter Lattke, Annett Paetzold, Werner Jaross, Hans-Ekbert Schroeder

Journal:

Clinica Chimica Acta

Year:

1996

Language:

english

File:

PDF, 735 KB

english, 1996

23

Relationship Between Diurnal Blood Pressure Variation and Diurnal Blood Glucose Levels in Type 2 Diabetic Patients

Frank Pistrosch, Eva Reissmann, Jan Wildbrett, Carsta Koehler, Markolf Hanefeld

Journal:

American Journal of Hypertension

Year:

2007

Language:

english

File:

PDF, 108 KB

english, 2007

24

Postprandial glucose regulation: New data andnew implications

Lawrence A. Leiter, Antonio Ceriello, Jaime A. Davidson, Markolf Hanefeld, Louis Monnier, David R. Owens, Naoko Tajima, Jaakko Tuomilehto

Journal:

Clinical Therapeutics

Year:

2005

Language:

english

File:

PDF, 1.86 MB

english, 2005

25

Elevated fasting glucose levels predicts IGT and diabetes also in middle-age subjects

Peter E.H. Schwarz, Stefan R. Bornstein, Markolf Hanefeld

Journal:

Diabetes Research and Clinical Practice

Year:

2007

Language:

english

File:

PDF, 92 KB

english, 2007

26

Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus

Elena Henkel, Mario Menschikowski, Carsta Koehler, Wolfgang Leonhardt, Markolf Hanefeld

Journal:

Year:

2005

Language:

english

File:

PDF, 121 KB

english, 2005

27

A one-year study comparing the efficacy and safety of rosiglitazone and glibenclamide in the treatment of type 2 diabetes

Markolf Hanefeld, Rita Patwardhan, Nigel P. Jones

Journal:

Nutrition, Metabolism and Cardiovascular Diseases

Year:

2007

Language:

english

File:

PDF, 227 KB

english, 2007

28

Postprandial hyperglycaemia and cardiovascular complications of diabetes: An update

Antonio Ceriello, Jamie Davidson, Markolf Hanefeld, Lawrence Leiter, Louis Monnier, David Owens, Naoko Tajima, Jaakko Tuomilehto

Journal:

Nutrition, Metabolism and Cardiovascular Diseases

Year:

2006

Language:

english

File:

PDF, 101 KB

english, 2006

29

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial

Jean-Louis Chiasson, Robert G Josse, Ramon Gomis, Markolf Hanefeld, Avraham Karasik, Markku Laakso

Journal:

Year:

2002

Language:

english

File:

PDF, 469 KB

english, 2002

30

Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial

Philip D Home, Stuart J Pocock, Henning Beck-Nielsen, Paula S Curtis, Ramon Gomis, Markolf Hanefeld, Nigel P Jones, Michel Komajda, John JV McMurray

Journal:

Year:

2009

Language:

english

File:

PDF, 443 KB

english, 2009

31

Dapagliflozin, an SGLT2 inhibitor, for diabetes

Markolf Hanefeld, Thomas Forst

Journal:

Year:

2010

Language:

english

File:

PDF, 90 KB

english, 2010

32

Dipeptidyl peptidase IV (DP IV)-modulations as treatment of impaired glucose tolerance and niddm

Hans-Ulrich Demuth, Konrad Glund, Jose Banke-Bochita, Karl-Ludwig Rost, Sabine Fischer, Markolf Hanefeld, Christopher H.S. McIntosh, Raymond A. Pederson

Journal:

Regulatory Peptides

Year:

2000

Language:

english

File:

PDF, 119 KB

english, 2000

33

Frequency and severity of insulin resistance in type 2 diabetes

Sabine Fischer, Carsta Koehler, Wolfgang Metzler, Markolf Hanefeld

Journal:

Diabetes Research and Clinical Practice

Year:

2000

Language:

english

File:

PDF, 110 KB

english, 2000

34

Protective effect of the pro12Ala variant of the human peroxisome proliferator activated receptor γ2 on obesity, insulin sensitivity and glucose tolerance

Theodora S Temelkova-Kurktschiev, Markku Laakso, Wolfgang Leonhardt, Markolf Hanefeld

Journal:

Diabetes Research and Clinical Practice

Year:

2000

Language:

english

File:

PDF, 143 KB

english, 2000

35

Should antidiabetic treatment of type 2 diabetes in patients with heart failure differ from that in patients without?

Gitt, Anselm K., Halle, Martin, Hanefeld, Markolf, Kellerer, Monika, Marx, Nikolaus, Meier, Juris J., Schumm-Draeger, Petra-Maria, Bramlage, Peter, Tschöpe, Diethelm

Journal:

European Journal of Heart Failure

Year:

2012

Language:

english

File:

PDF, 189 KB

english, 2012

36

Effects of pioglitazone and/or simvastatin on low density lipoprotein subfractions in non-diabetic patients with high cardiovascular risk: A sub-analysis from the PIOSTAT study

Wolfgang Leonhardt, Andreas Pfützner, Jürgen Müller, Jens Pietzsch, Thomas Forst, Efstrathios Karagiannis, Georg Lübben, Markolf Hanefeld

Journal:

Atherosclerosis

Year:

2008

Language:

english

File:

PDF, 191 KB

english, 2008

37

Introduction: New approaches to managing diabetic dyslipidaemia

Hanefeld, Markolf

Journal:

Atherosclerosis Supplements

Year:

2005

Language:

english

File:

PDF, 40 KB

english, 2005

38

Anti-Inflammatory Effects of Pioglitazone and/or Simvastatin in High Cardiovascular Risk Patients With Elevated High Sensitivity C-Reactive Protein: The PIOSTAT Study

Markolf Hanefeld, Nikolaus Marx, Andreas Pfützner, Werner Baurecht, Georg Lübben, Efstrathios Karagiannis, Ulf Stier, Thomas Forst

Journal:

Journal of the American College of Cardiology

Year:

2007

Language:

english

File:

PDF, 239 KB

english, 2007

39

The Effect of Darapladib on Plasma Lipoprotein-Associated Phospholipase A2 Activity and Cardiovascular Biomarkers in Patients With Stable Coronary Heart Disease or Coronary Heart Disease Risk Equivalent: The Results of a Multicenter, Randomized, Double-Blind, Placebo-Controlled Study

Emile R. Mohler III, Christie M. Ballantyne, Michael H. Davidson, Markolf Hanefeld, Luis M. Ruilope, Joel L. Johnson, Andrew Zalewski

Journal:

Journal of the American College of Cardiology

Year:

2008

Language:

english

File:

PDF, 265 KB

english, 2008

40

Effect of simvastatin and/or pioglitazone on insulin resistance, insulin secretion, adiponectin, and proinsulin levels in nondiabetic patients at cardiovascular risk—the PIOSTAT Study

Thomas Forst, Andreas Pfützner, Georg Lübben, Matthias Weber, Nikolaus Marx, Efstrathios Karagiannis, Carsta Koehler, Werner Baurecht, Cloth Hohberg, Markolf Hanefeld

Journal:

Year:

2007

Language:

english

File:

PDF, 211 KB

english, 2007

41

Light-to-moderate alcohol consumption, risk factor profile and early atherosclerosis: the RIAD Study

Theodora Temelkova-Kurktschiev, Elena Henkel, Carsta Koehler, Markolf Hanefeld

Journal:

Atherosclerosis

Year:

2001

Language:

english

File:

PDF, 52 KB

english, 2001

42

Diminished susceptibility to in vitro oxidation of low-density lipoproteins in hypercholesterolemia: key role of alpha-tocopherol content

Wolfgang Leonhardt, Markolf Hanefeld, Frank Schaper

Journal:

Atherosclerosis

Year:

1999

Language:

english

File:

PDF, 73 KB

english, 1999

43

The Metabolic Syndrome at the Beginning of the XXI Century || Dyslipidemia in the Metabolic Syndrome

Hanefeld, Markolf

Year:

2005

File:

PDF, 222 KB

2005

44

The role of co-morbidity in the selection of antidiabetic pharmacotherapy in type-2 diabetes

Diethelm Tschöpe, Markolf Hanefeld, Juris J Meier…

Journal:

Cardiovascular Diabetology

Year:

2013

Language:

english

File:

PDF, 266 KB

english, 2013

45

Insulin Use Early in the Course of Type 2 Diabetes Mellitus: The ORIGIN Trial

Markolf Hanefeld, Peter Bramlage

Journal:

Current Diabetes Reports

Year:

2013

Language:

english

File:

PDF, 392 KB

english, 2013

46

Cardiac implications of hypoglycaemia in patients with diabetes – a systematic review

Hanefeld, Markolf, Duetting, Eva, Bramlage, Peter

Journal:

Cardiovascular Diabetology

Year:

2013

Language:

english

File:

PDF, 346 KB

english, 2013

47

Basal insulin glargine and microvascular outcomes in dysglycaemic individuals: results of the Outcome Reduction with an Initial Glargine Intervention (ORIGIN) trial

Gilbert, Richard E., Mann, Johannes F. E., Hanefeld, Markolf, Spinas, Giatgen, Bosch, Jackie, Yusuf, Salim, Gerstein, Hertzel C.

Journal:

Year:

2014

Language:

english

File:

PDF, 500 KB

english, 2014

48

Predictors of Response to Early Basal Insulin Treatment in Patients with Type 2 Diabetes—The EARLY Experience

Hanefeld, Markolf, Fleischmann, Holger, Schiffhorst, Guido, Bramlage, Peter

Journal:

Diabetes Technology & Therapeutics

Year:

2014

Language:

english

File:

PDF, 168 KB

english, 2014

49

EFFECTS OF ALEGLITAZAR ON CARDIOVASCULAR RISK FACTORS IN PATIENTS WITH STAGE 3 CHRONIC KIDNEY DISEASE AND TYPE II DIABETES

Malmberg, Klas, Hanefeld, Markolf, Ruilope, Luis, Lincoff, A., Viberti, Giancarlo, Mudie, Nadejda, Urbanowska, Teresa

Journal:

Journal of the American College of Cardiology

Year:

2013

Language:

english

File:

PDF, 156 KB

english, 2013

50

Vacancies

Hanefeld, Markolf

Journal:

Year:

1931

Language:

english

File:

PDF, 219 KB

english, 1931